CNS effects of histamine H-1 antagonists

Citation
Jp. Rihoux et F. Donnelly, CNS effects of histamine H-1 antagonists, CLIN EXP AL, 29, 1999, pp. 143-146
Citations number
14
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
CLINICAL AND EXPERIMENTAL ALLERGY
ISSN journal
09547894 → ACNP
Volume
29
Year of publication
1999
Supplement
3
Pages
143 - 146
Database
ISI
SICI code
0954-7894(199907)29:<143:CEOHHA>2.0.ZU;2-5
Abstract
An accurate evaluation of the functions of the human brain during the admin istration of drugs is one of the most complex tasks in medical science. In the case of H-1 antihistamines, there are many biases that can explain why the interpretation of pharmacological data and those from clinical studies can be very difficult. First of all, the allergic disease itself may modify central nervous system (CNS) functioning and effective medical treatment m ay accordingly influence the self-reported CNS sensations of patients. More over, the carefully selected populations that are enrolled both in pharmaco logical and clinical studies do not reflect the profile of patients who are trreated with such drugs on an everyday basis. Finally, studies of perform ance impairment and those relying on self-reported sensations may give diff erent and indeed conflicting results. It may be concluded that the various pronouncements on the CNS properties of H1 antihistamines must be treated w ith some caution.